Evera
Device Implantable Cardioverter Defibrillators (ICDs)
General payments
$63,903
Research payments
$226,552
Through program year 2020, $63,903 in general payments and $226,552 in research payments were reported against Evera (Implantable Cardioverter Defibrillators (ICDs)).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $14,019 | 522 |
| 2020 | Research | $63,211 | 44 |
| 2019 | General | $49,884 | 1,011 |
| 2019 | Research | $163,341 | 38 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.
The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
The top 5 of 34 states; each share is of general payments naming this product in 2020 where a state was reported.
Records
1,533 general · 82 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.